Ashaunta T. Anderson is a Robert Wood Johnson Clinical Scholar at the University of California in Los Angeles, California.Nina L. Shapiro is the Director of Pediatric Otolaryngology and an Associate Professor of Head and Neck Surgery at the UCLA David Geffen School of Medicine in Los Angeles, California.Stephen C. Aronoff is the Waldo E. Nelson Professor and Chairman of Pediatrics at Temple University in Philadelphia, Pennsylvania. Jeremiah Davis is a Pediatric Resident at Seattle Children's Hospital and the University of Washington in Seattle, Washington. Michael Levy is a Pediatric Clinical Lecturer at the University of Michigan and C.S. Mott Children's Hospital which in Ann Arbor, Michigan.

The book is an impressive testament to the thousands of patients, hundreds of researchers, and multiple funding sources that together have helped provide the empirical foundation for our current approaches to the treatment of psychiatric disorders.

• Section I: Allergy Immunology1. Efficacy of Immunoglobulin Plus Prednisolone in Prevention of Coronary Artery Abnormalities in Kawasaki Disease Section II: Behavioral 2. Measles, Mumps, and Rubella Vaccination and Autism3. Treatment for adolescents with depression study (TADS)4. The Multimodal Treatment Study of Children with Attention Deficit/Hyperactivity Disorder (MTA) Section III: Cardiology5. Pharmacologic Closure of a Patent Ductus Arteriosus in Premature Infants6. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa heart study Section IV: Dermatology7. Propranolol vs. Prednisolone for Symptomatic Proliferating Infantile Hemangiomas: A Randomized Clinical TrialSection V: Endocrinology8. Risk Factors for Cerebral Edema in Children with Diabetic KetoacidosisSection VI: ENT9. A Trial of Early Ear Tube Placement in Children with Persistent Otitis Media Section VII: General Pediatrics10. Maintenance IV Fluid Requirements11. Predischarge Serum Bilirubin to Predict Significant Hyperbilirubinemia in Newborns12. Sudden Infant Death Syndrome Risk Factors: The Chicago Infant Mortality Study13. Treatment of Acute Otitis Media in Children14. The Human Papillomavirus Vaccine15. Evidence of Decrease in Vaccine-Type Human Papillomavirus (HPV) and Herd Protection in Adolescents and Young Women16. Effects of Lead Exposure in Childhood Section VIII: Hematology17. Iron Supplementation for Breastfed Infants18. Transfusion Strategies for Patients in Pediatric Intensive Care Units19. Prophylactic Penicillin in Sickle Cell Anemia Section IX: Infectious Disease20. Empiric Antimicrobial Therapy for Skin and Soft-Tissue Infections21. Infants at Low Risk for Serious Bacterial Infection 22. Outpatient Treatment of Febrile Infants at Low Risk for Serious Bacterial Infection23. Outpatient Treatment of Selected Febrile Infants Without Antibiotics24. Neonatal Fever Without a Source25. Serious Bacterial Infections and Viral Infections in Febrile Infants26. Chest Radiograph and Lower Respiratory Tract Infection27. Vidarabine Therapy of Neonatal Herpes Simplex Virus Infection28. Early Reversal of Pediatric and Neonatal Septic Shock29. Reduction of vertical transmission of human immunodeficiency virus (HIV)30. Palivizumab prophylaxis against Respiratory Syncytial Virus (RSV) in high risk infants31. The Spectrum of Bronchiolitis32. Preventing Early-Onset Neonatal Group B Streptococcal Disease Section X: Neonatology33. Apgar Scoring of Infants at Delivery34. Prophylactic Treatment with Human Surfactant in Extremely Preterm Infants Section XI: Nephrology35. Oral versus Initial Intravenous Antibiotics for Urinary Tract Infection in Young Febrile Children36. Identifying children with minimal change disease (MCD)37. Chronic renal disease following poststreptococcal glomerulonephritis Section XII: Neurology38. Antipyretic Agents for Preventing Febrile Seizure Recurrence39. Febrile Seizures and Risk for Epilepsy40. Seizure Recurrence After First Unprovoked Afebrile Seizure41. Mortality and Childhood-Onset Epilepsy42. Identifying Children with Low-Risk Head Injuries Who Do Not Require Computed Tomography Section XIII: Oncology43. Health-Related Quality of Life Among Children with Acute Lymphoblastic Leukemia Section XIV: Ophthalmology44. Treatment of Acute Conjunctivitis in Children45. Screening for Amblyopia Section XV: Orthopedics46. Differentiation Between Septic Arthritis and Transient Synovitis of the Hip in Children Section XVI: Pulmonary 47. Steroids for the Treatment of Croup48. Inhaled Corticosteroids for Mild Persistent Asthma49. Inhaled Salbutamol (Albuterol) vs. Injected Epinephrine in Acute Asthma50. Long-term Inhaled Hypertonic Saline for Cystic Fibrosis

Ashaunta T. Anderson is a Robert Wood Johnson Clinical Scholar at the University of California in Los Angeles, California.Nina L. Shapiro is the Director of Pediatric Otolaryngology and an Associate Professor of Head and Neck Surgery at the UCLA David Geffen School of Medicine in Los Angeles, California.Stephen C. Aronoff is the Waldo E. Nelson Professor and Chairman of Pediatrics at Temple University in Philadelphia, Pennsylvania. Jeremiah Davis is a Pediatric Resident at Seattle Children's Hospital and the University of Washington in Seattle, Washington. Michael Levy is a Pediatric Clinical Lecturer at the University of Michigan and C.S. Mott Children's Hospital which in Ann Arbor, Michigan.

The book is an impressive testament to the thousands of patients, hundreds of researchers, and multiple funding sources that together have helped provide the empirical foundation for our current approaches to the treatment of psychiatric disorders.

• Section I: Allergy Immunology1. Efficacy of Immunoglobulin Plus Prednisolone in Prevention of Coronary Artery Abnormalities in Kawasaki Disease Section II: Behavioral 2. Measles, Mumps, and Rubella Vaccination and Autism3. Treatment for adolescents with depression study (TADS)4. The Multimodal Treatment Study of Children with Attention Deficit/Hyperactivity Disorder (MTA) Section III: Cardiology5. Pharmacologic Closure of a Patent Ductus Arteriosus in Premature Infants6. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa heart study Section IV: Dermatology7. Propranolol vs. Prednisolone for Symptomatic Proliferating Infantile Hemangiomas: A Randomized Clinical TrialSection V: Endocrinology8. Risk Factors for Cerebral Edema in Children with Diabetic KetoacidosisSection VI: ENT9. A Trial of Early Ear Tube Placement in Children with Persistent Otitis Media Section VII: General Pediatrics10. Maintenance IV Fluid Requirements11. Predischarge Serum Bilirubin to Predict Significant Hyperbilirubinemia in Newborns12. Sudden Infant Death Syndrome Risk Factors: The Chicago Infant Mortality Study13. Treatment of Acute Otitis Media in Children14. The Human Papillomavirus Vaccine15. Evidence of Decrease in Vaccine-Type Human Papillomavirus (HPV) and Herd Protection in Adolescents and Young Women16. Effects of Lead Exposure in Childhood Section VIII: Hematology17. Iron Supplementation for Breastfed Infants18. Transfusion Strategies for Patients in Pediatric Intensive Care Units19. Prophylactic Penicillin in Sickle Cell Anemia Section IX: Infectious Disease20. Empiric Antimicrobial Therapy for Skin and Soft-Tissue Infections21. Infants at Low Risk for Serious Bacterial Infection 22. Outpatient Treatment of Febrile Infants at Low Risk for Serious Bacterial Infection23. Outpatient Treatment of Selected Febrile Infants Without Antibiotics24. Neonatal Fever Without a Source25. Serious Bacterial Infections and Viral Infections in Febrile Infants26. Chest Radiograph and Lower Respiratory Tract Infection27. Vidarabine Therapy of Neonatal Herpes Simplex Virus Infection28. Early Reversal of Pediatric and Neonatal Septic Shock29. Reduction of vertical transmission of human immunodeficiency virus (HIV)30. Palivizumab prophylaxis against Respiratory Syncytial Virus (RSV) in high risk infants31. The Spectrum of Bronchiolitis32. Preventing Early-Onset Neonatal Group B Streptococcal Disease Section X: Neonatology33. Apgar Scoring of Infants at Delivery34. Prophylactic Treatment with Human Surfactant in Extremely Preterm Infants Section XI: Nephrology35. Oral versus Initial Intravenous Antibiotics for Urinary Tract Infection in Young Febrile Children36. Identifying children with minimal change disease (MCD)37. Chronic renal disease following poststreptococcal glomerulonephritis Section XII: Neurology38. Antipyretic Agents for Preventing Febrile Seizure Recurrence39. Febrile Seizures and Risk for Epilepsy40. Seizure Recurrence After First Unprovoked Afebrile Seizure41. Mortality and Childhood-Onset Epilepsy42. Identifying Children with Low-Risk Head Injuries Who Do Not Require Computed Tomography Section XIII: Oncology43. Health-Related Quality of Life Among Children with Acute Lymphoblastic Leukemia Section XIV: Ophthalmology44. Treatment of Acute Conjunctivitis in Children45. Screening for Amblyopia Section XV: Orthopedics46. Differentiation Between Septic Arthritis and Transient Synovitis of the Hip in Children Section XVI: Pulmonary 47. Steroids for the Treatment of Croup48. Inhaled Corticosteroids for Mild Persistent Asthma49. Inhaled Salbutamol (Albuterol) vs. Injected Epinephrine in Acute Asthma50. Long-term Inhaled Hypertonic Saline for Cystic Fibrosis